John W. Childs - 04 Mar 2025 Form 4/A - Amendment Insider Report for Biohaven Ltd. (BHVN)

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Issuer symbol
BHVN
Transactions as of
04 Mar 2025
Net transactions value
+$864,115
Form type
4/A - Amendment
Filing time
09 Mar 2026, 18:12:05 UTC
Date Of Original Report
05 Mar 2025
Previous filing
31 Dec 2024
Next filing
07 May 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CHILDS JOHN W Director C/O BIOHAVEN LTD., 215 CHURCH STREET, NEW HAVEN /s/ George Clark, Attorney-in-Fact 09 Mar 2026 0001027035

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHVN Common Shares Purchase $864,115 +28,400 +1.2% $30.43 2,323,971 04 Mar 2025 By John W Childs 2013 Revocable Trust F1, F2
holding BHVN Common Shares 73,170 04 Mar 2025 By 2013 Charitable Remainder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed to correct the nature of the indirect ownership reported in the Form 4 filed on March 5, 2025 (the "Original Form 4"). The Original Form 4 inadvertently misstated that 3,400 Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust, and 25,000 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust. However, as reflected in this amendment, 28,400 Common Shares were indirectly acquired by the Reporting Person through the John W Childs 2013 Revocable Trust, and no Common Shares were indirectly acquired by the Reporting Person through the 2013 Charitable Remainder Trust.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.17 - $30.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.